Here are relevant reports on : biopharmaceutical

Risk Based Monitoring Software Market Size by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2025

The size of global risk based monitoring software market in terms of revenue was estimated to be worth USD 273 million in 2020 and is poised to reach USD 511 million by 2025, growing at a CAGR of 13.3% from 2020 to 2025. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: May 2020
- Price: $ 4950
- TOC Available: